MedTrace Logo

Neuromodulation of Ankle Muscles in Persons With SCI

NCT04238013 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2022-06-22

No results posted yet for this study

Summary

The ability to voluntarily move the ankles is important for walking. After spinal cord injury (SCI), this ability is impaired because of changes in the communication between the brain, spinal cord, and body. Whole body vibration (WBV) is a treatment that increases voluntary muscle control and decreases uncontrollable muscle movement in people with SCI. The purpose of this study is to understand how WBV can impact ankle control and uncontrollable muscle movement.

Conditions

  • Spinal Cord Injuries
  • Spastic Gait
  • Foot Drop

Interventions

OTHER

Whole Body Vibration (WBV)

The WBV session will consist of 8 bouts of 45s vibration (50Hz) with a minute of rest in between each bout.

OTHER

Electrical Stimulation

The electrical stimulation intervention serves to account for any effects of standing and/or of repeated performance of the sit-to-stand behavior on neurophysiological outcomes. In the electrical stimulation intervention, participants will receive electrical stimulation while standing on the vibration platform for 8 bouts for 45s with a minute of rest in between without vibration.

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Shepherd Center, Atlanta GA

    lead OTHER

Principal Investigators

  • Edelle Field-Fote, PT, PhD · Director of Spinal Cord Injury Research

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-06
Primary Completion
2021-07-09
Completion
2021-07-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04238013 on ClinicalTrials.gov